English

Eligibility Breast Cancer NCT01725386

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult female patients, >/= 18 years of age
Description

Adult | Gender | Age

Data type

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0079399
UMLS CUI [3]
C0001779
cytolologic/histopathologic confirmed diagnosis of metastatic breast cancer
Description

Secondary malignant neoplasm of female breast

Data type

boolean

Alias
UMLS CUI [1]
C0346993
prescribed xeloda as in routine clinical practice
Description

Xeloda prescribed

Data type

boolean

Alias
UMLS CUI [1,1]
C0724419
UMLS CUI [1,2]
C0278329
informed consent signed
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
participation in any other clinical trial
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
history of severe and unexpected reactions to fluoropyrimidine therapy
Description

Severe reaction Unexpected Fluoropyrimidine

Data type

boolean

Alias
UMLS CUI [1,1]
C3242604
UMLS CUI [1,2]
C4055646
UMLS CUI [1,3]
C0596581
hypersensitivity to capecitabine or to any of the excipients of fluorouracil
Description

Hypersensitivity Capecitabine | Hypersensitivity Fluorouracil Excipient

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0671970
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0016360
UMLS CUI [2,3]
C0015237
known dihydropyrimidine dehydrogenase (dpd) deficiency
Description

Dihydropyrimidine Dehydrogenase Deficiency

Data type

boolean

Alias
UMLS CUI [1]
C1959620
pregnant or lactating women
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
severe leucopenia, neutropenia, or thrombocytopenia
Description

Leukopenia Severe | Neutropenia Severe | Thrombocytopenia Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0023530
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0027947
UMLS CUI [2,2]
C0205082
UMLS CUI [3,1]
C0040034
UMLS CUI [3,2]
C0205082
severe hepatic impairment
Description

Hepatic impairment Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0948807
UMLS CUI [1,2]
C0205082
severe renal impairment (creatinine clearance below 30 ml/min)
Description

Renal Insufficiency Severe | Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1,1]
C1565489
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C0201976
treatment with sorivudine or its chemically related analogues, such as brivudine
Description

sorivudine | Sorivudine Analogue | brivudine

Data type

boolean

Alias
UMLS CUI [1]
C0207628
UMLS CUI [2,1]
C0207628
UMLS CUI [2,2]
C0243071
UMLS CUI [3]
C0163272
refusal to give consent
Description

Informed Consent Refused

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1705116
Back to the top of the page

Similar models

Eligibility Breast Cancer NCT01725386

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Gender | Age
Item
adult female patients, >/= 18 years of age
boolean
C0001675 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
Secondary malignant neoplasm of female breast
Item
cytolologic/histopathologic confirmed diagnosis of metastatic breast cancer
boolean
C0346993 (UMLS CUI [1])
Xeloda prescribed
Item
prescribed xeloda as in routine clinical practice
boolean
C0724419 (UMLS CUI [1,1])
C0278329 (UMLS CUI [1,2])
Informed Consent
Item
informed consent signed
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Study Subject Participation Status
Item
participation in any other clinical trial
boolean
C2348568 (UMLS CUI [1])
Severe reaction Unexpected Fluoropyrimidine
Item
history of severe and unexpected reactions to fluoropyrimidine therapy
boolean
C3242604 (UMLS CUI [1,1])
C4055646 (UMLS CUI [1,2])
C0596581 (UMLS CUI [1,3])
Hypersensitivity Capecitabine | Hypersensitivity Fluorouracil Excipient
Item
hypersensitivity to capecitabine or to any of the excipients of fluorouracil
boolean
C0020517 (UMLS CUI [1,1])
C0671970 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0016360 (UMLS CUI [2,2])
C0015237 (UMLS CUI [2,3])
Dihydropyrimidine Dehydrogenase Deficiency
Item
known dihydropyrimidine dehydrogenase (dpd) deficiency
boolean
C1959620 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Leukopenia Severe | Neutropenia Severe | Thrombocytopenia Severe
Item
severe leucopenia, neutropenia, or thrombocytopenia
boolean
C0023530 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0027947 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0040034 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
Hepatic impairment Severe
Item
severe hepatic impairment
boolean
C0948807 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Renal Insufficiency Severe | Creatinine measurement, serum
Item
severe renal impairment (creatinine clearance below 30 ml/min)
boolean
C1565489 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0201976 (UMLS CUI [2])
sorivudine | Sorivudine Analogue | brivudine
Item
treatment with sorivudine or its chemically related analogues, such as brivudine
boolean
C0207628 (UMLS CUI [1])
C0207628 (UMLS CUI [2,1])
C0243071 (UMLS CUI [2,2])
C0163272 (UMLS CUI [3])
Informed Consent Refused
Item
refusal to give consent
boolean
C0021430 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])
Back to the top of the page